Valuation: Cochlear Limited

Market Cap 9.27B 6.51B 5.82B 5.38B 4.88B 9.13B 619B 64.8B 25.63B 324B 24.43B 23.91B 1,026B P/E 2027 *
31.5x
P/E 2028 * 25x
Enterprise Value 9.04B 6.35B 5.68B 5.25B 4.75B 8.9B 604B 63.19B 24.99B 316B 23.82B 23.31B 1,000B EV / Sales 2027 *
3.82x
EV / Sales 2028 * 3.59x
Free-Float
99.42%
Yield 2027 *
2.53%
Yield 2028 * 2.8%
1 day-1.48%
1 week+0.23%
Current month+0.09%
1 month-3.73%
3 months+22.03%
6 months+46.69%
Current year-46.40%
1 week 138.22
Extreme 138.22
146.81
1 month 124.33
Extreme 124.33
146.81
Current year 88.74
Extreme 88.74
278.35
1 year 88.74
Extreme 88.74
296.5
3 years 88.74
Extreme 88.74
350.31
5 years 88.74
Extreme 88.74
350.31
10 years 88.74
Extreme 88.74
350.31
Manager TitleAgeSince
Chief Executive Officer - 03/01/2018
Director of Finance/CFO - 01/01/2025
Chief Tech/Sci/R&D Officer - 01/07/2019
Director TitleAgeSince
Chairman 58 21/08/2021
Director/Board Member - 14/11/2017
Director/Board Member 69 13/12/2016
Date Insider Type Main position Quantity % Market Cap. Importance
01/09/26 Buy

Director

1,100 0.0017%
24/08/26 Buy

Director

444 0.0007%
24/08/26 Buy

Director

257 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
-1.70%+0.23% - - 6.75B
Average -1.48%
Weighted average by Cap. -1.48%

Financials

2027 *2028 *
Net sales 2.37B 1.66B 1.49B 1.37B 1.24B 2.33B 158B 16.55B 6.54B 82.7B 6.24B 6.1B 262B 2.5B 1.75B 1.57B 1.45B 1.31B 2.46B 167B 17.46B 6.91B 87.3B 6.58B 6.44B 276B
Net income 292M 205M 183M 170M 154M 287M 19.5B 2.04B 807M 10.2B 769M 753M 32.3B 369M 259M 232M 215M 194M 364M 24.67B 2.58B 1.02B 12.9B 973M 952M 40.85B
Net Debt -231M -162M -145M -134M -121M -227M -15.42B -1.61B -638M -8.06B -608M -595M -25.53B -313M -219M -196M -182M -164M -308M -20.88B -2.19B -864M -10.92B -824M -806M -34.58B
Projected Income Statement - Annual - Cochlear Limited
Logo Cochlear Limited
Cochlear Limited provides implantable hearing solutions and a range of implants and sound processor upgrades. Its segments include Cochlear Implants, Services and Acoustics. The Cochlear Implants segment offers Cochlear implant systems. The Services segment offers sound processor upgrades, accessories and other. The Acoustics segment offers bone conduction systems and sound processor upgrades. Its products and services portfolio include Cochlear implant portfolio, Acoustic solutions portfolio, Recipient support tools, and Cochlear Connected Care solutions. Its Cochlear Connected Care solutions include Cochlear Nucleus SmartNav System, Cochlear Custom Sound Pro Fitting Software, Cochlear Link, Cochlear Remote Assist, and Cochlear Remote Check. Cochlear implant portfolio includes Cochlear Nucleus System. Acoustic solutions portfolio includes Cochlear Osia System, and Cochlear Baha System. Recipient support tools include Cochlear Nucleus, Baha and Osia Smart Apps and Cochlear CoPilot App.
Employees
5,400
Date Price Change Volume
27/10/26 A$139.41 -1.70% 95,472
26/10/26 A$141.82 -3.40% 446,725
23/10/26 A$146.81 +4.42% 360,578
22/10/26 A$140.59 -0.62% 254,983
21/10/26 A$141.47 +1.48% 1,333,791
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - Cochlear Limited
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
16
Last Close Price
141.82AUD
Average target price
136.34AUD
Spread / Average Target
-3.86%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Cochlear Limited